{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T10:16:32Z","timestamp":1795169792008,"version":"4.10.3"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lung transplant (LT) recipients are at high risk for severe respiratory syncytial virus (RSV) infection, but predictors of worse outcomes remain poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective multicenter cohort study of adult LT recipients hospitalized with polymerase chain reaction\u2013confirmed RSV infection between January 2016 and December 2019. Clinical characteristics, treatments, and outcomes within 90 days were analyzed. Logistic regression was used to identify predictors of outcomes, while Cox proportional hazards models assessed risk factors for mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 155 LT recipients were included. Their median age was 61 years, and RSV infection occurred a median of 14 months after transplantation. Risk factors for hypoxic respiratory failure were baseline oxygen use (odds ratio [OR], 4.81 [95% confidence interval (CI), 1.29\u201323.93]) and lower respiratory tract symptoms (3.74 [1.49\u201310.18]). Older age increased the risk of mechanical ventilation (MV) (OR, 1.06 [95% CI, 1.02\u20131.12]), while oral ribavirin was associated with reduced risk (0.34 [.14\u2013.82]); this association was attenuated when oral and inhaled ribavirin were combined into a single exposure variable (0.77 [.22\u20132.66]); oral ribavirin was not associated with reduced 90-day mortality rate (hazard ratio, 5.27 [95% CI, .68\u201340.83]). Secondary bacterial or fungal infections occurred in 33.5%, associated with prior MV. Lung function declined significantly after RSV infection, with nearly half experiencing &amp;gt;10% decrease in forced expiratory volume in 1 second. The 90-day all-cause mortality rate was 7.7%, with MV associated with death (hazard ratio, 7.79 [95% CI, 2.47\u201324.60]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>RSV infection in LT recipients is associated with a high morbidity rate, graft function decline, and increased mortality risk. The association between older age and severe outcomes suggests the importance of preventive strategies in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag623","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:39:21Z","timestamp":1791027561000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors for Hypoxia, Mechanical Ventilation, and Mortality in Lung Transplant Recipients Hospitalized With Respiratory Syncytial Virus: A Multicenter International Cohort Study"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3822-0669","authenticated-orcid":false,"given":"Maria Alejandra","family":"Mendoza","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of Utah , Salt Lake City, Utah ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1730-5604","authenticated-orcid":false,"given":"Mitchell","family":"Dumais","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5241-3435","authenticated-orcid":false,"given":"Chia-Yu","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of Colorado , Aurora, Colorado ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1845-4476","authenticated-orcid":false,"given":"Beatrice Z","family":"Sim","sequence":"additional","affiliation":[{"name":"Victorian Infectious Diseases Department, Royal Melbourne Hospital , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-4145","authenticated-orcid":false,"given":"Michelle K","family":"Yong","sequence":"additional","affiliation":[{"name":"Victorian Infectious Diseases Department, Royal Melbourne Hospital , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayyadah","family":"Alabdely","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Integrated Hospital-Care Institute, Cleveland Clinic , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2098-2868","authenticated-orcid":false,"given":"Zachary A","family":"Yetmar","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Integrated Hospital-Care Institute, Cleveland Clinic , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Pennington","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8330-7734","authenticated-orcid":false,"given":"Aaron D","family":"Mishkin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Lewis Katz School of Medicine at Temple University , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Moran","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai , New York, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Humar","sequence":"additional","affiliation":[{"name":"Department of Transplant Infectious Diseases, University Health Network , Toronto, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Diaz Alvarez","sequence":"additional","affiliation":[{"name":"Department of Transplant Infectious Diseases, University Health Network , Toronto, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Medicine, University of Miami Miller School of Medicine , Miami, Florida ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria G","family":"Hall","sequence":"additional","affiliation":[{"name":"Victorian Infectious Diseases Department, Royal Melbourne Hospital , Melbourne, Victoria ,","place":["Australia"]},{"name":"Department of Transplant Infectious Diseases, University Health Network , Toronto, Ontario ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5248-0227","authenticated-orcid":false,"given":"Raymund R","family":"Razonable","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases and Occupational Medicine and the William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic , Rochester, Minnesota ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4938-125X","authenticated-orcid":false,"given":"Yoichiro","family":"Natori","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Medicine, University of Miami Miller School of Medicine , Miami, Florida ,","place":["USA"]},{"name":"Miami Transplant Institute, Jackson Health System , Miami, Florida ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"2026112004315130700_ofag623-B1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1086\/653529","article-title":"Upper and lower respiratory tract viral infections and acute graft rejection in lung transplant recipients","volume":"51","author":"Soccal","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2026112004315130700_ofag623-B2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1600-6143.2011.03490.x","article-title":"Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies","volume":"11","author":"Vu","year":"2011","journal-title":"Am J Transplant"},{"key":"2026112004315130700_ofag623-B3","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/ajt.16383","article-title":"Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study","volume":"21","author":"Mombelli","year":"2021","journal-title":"Am J Transplant"},{"key":"2026112004315130700_ofag623-B4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1055\/s-0030-1249120","article-title":"Viral infections in lung transplant recipients","volume":"31","author":"Shah","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"2026112004315130700_ofag623-B5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12916-023-02932-5","article-title":"Understanding the age spectrum of respiratory syncytial virus associated hospitalisation and mortality burden based on statistical modelling methods: a systematic analysis","volume":"21","author":"Cong","year":"2023","journal-title":"BMC Med"},{"key":"2026112004315130700_ofag623-B6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijid.2017.07.011","article-title":"Respiratory viruses in transplant recipients: more than just a cold: clinical syndromes and infection prevention principles","volume":"62","author":"Abbas","year":"2017","journal-title":"Int J Infect Dis"},{"key":"2026112004315130700_ofag623-B7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/thoraxjnl-2013-203581","article-title":"Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study","volume":"69","author":"Bridevaux","year":"2014","journal-title":"Thorax"},{"key":"2026112004315130700_ofag623-B8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/pathogens14010020","article-title":"Advances and challenges in antiviral development for respiratory viruses","volume":"14","author":"De Jesus-Gonzalez","year":"2024","journal-title":"Pathogens"},{"key":"2026112004315130700_ofag623-B9","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2026112004315130700_ofag623-B10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.healun.2011.01.701","article-title":"A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients","volume":"30","author":"Husain","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2026112004315130700_ofag623-B11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.12.2.298","article-title":"Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment","volume":"12","author":"Domachowske","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"2026112004315130700_ofag623-B12","first-page":"94","article-title":"Respiratory syncytial virus bronchiolitis in children","volume":"95","author":"Smith","year":"2017","journal-title":"Am Fam Physician"},{"key":"2026112004315130700_ofag623-B13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1148\/radiology.213.3.r99dc25735","article-title":"Respiratory viral infections in lung transplant recipients: radiologic findings with clinical correlation","volume":"213","author":"Matar","year":"1999","journal-title":"Radiology"},{"key":"2026112004315130700_ofag623-B14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/ajt.14042","article-title":"Epidemiology and immediate indirect effects of respiratory viruses in lung transplant recipients: a 5-year prospective study","volume":"17","author":"Peghin","year":"2017","journal-title":"Am J Transplant"},{"key":"2026112004315130700_ofag623-B15","doi-asserted-by":"crossref","first-page":"e13661","DOI":"10.1111\/tid.13661","article-title":"Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection","volume":"23","author":"Mahan","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"2026112004315130700_ofag623-B16","doi-asserted-by":"crossref","first-page":"e12844","DOI":"10.1111\/tid.12844","article-title":"Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: a single-center retrospective cohort study and review of the literature","volume":"20","author":"Trang","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2026112004315130700_ofag623-B17","doi-asserted-by":"crossref","first-page":"ofad513","DOI":"10.1093\/ofid\/ofad513","article-title":"Systematic literature review of risk factors for poor outcomes among adults with respiratory syncytial virus infection in high-income countries","volume":"10","author":"Njue","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026112004315130700_ofag623-B18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026112004315130700_ofag623-B19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/tropicalmed8030148","article-title":"Bacterial coinfection and superinfection in respiratory syncytial virus-associated acute respiratory illness: prevalence, pathogens, initial antibiotic-prescribing patterns and outcomes","volume":"8","author":"Wongsurakiat","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"2026112004315130700_ofag623-B20","doi-asserted-by":"crossref","first-page":"ofaa546","DOI":"10.1093\/ofid\/ofaa546","article-title":"Respiratory syncytial virus infection: its propensity for bacterial coinfection and related mortality in elderly adults","volume":"7","author":"Godefroy","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2026112004315130700_ofag623-B21","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.3390\/jcm14134803","article-title":"Impact of RSV infection in transplant and immunocompromised population: incidence and co-infections: retrospective analysis of a single centre","volume":"14","author":"Solidoro","year":"2025","journal-title":"J Clin Med"},{"key":"2026112004315130700_ofag623-B22","doi-asserted-by":"crossref","first-page":"O939","DOI":"10.1111\/1469-0691.12650","article-title":"Environmental variables associated with an increased risk of invasive aspergillosis","volume":"20","author":"Garcia-Vidal","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2026112004315130700_ofag623-B23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1542\/peds.92.3.501","article-title":"Use of ribavirin in the treatment of respiratory syncytial virus infection","volume":"92","author":"Committee on Infectious Diseases","year":"1993","journal-title":"Pediatrics"},{"key":"2026112004315130700_ofag623-B24","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.healun.2015.01.009","article-title":"Oral ribavirin for respiratory syncytial virus infection after lung transplantation: efficacy and cost-efficiency","volume":"34","author":"Burrows","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"2026112004315130700_ofag623-B25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.healun.2008.10.008","article-title":"Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection","volume":"28","author":"Pelaez","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"2026112004315130700_ofag623-B26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.healun.2012.04.002","article-title":"Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation","volume":"31","author":"Li","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"2026112004315130700_ofag623-B27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1097\/TP.0000000000002985","article-title":"Oral and inhaled ribavirin treatment for respiratory syncytial virus infection in lung transplant recipients","volume":"104","author":"Permpalung","year":"2020","journal-title":"Transplantation"},{"key":"2026112004315130700_ofag623-B28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cmi.2020.07.050","article-title":"Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study","volume":"27","author":"Testaert","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2026112004315130700_ofag623-B29","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.transproceed.2021.08.037","article-title":"Oral ribavirin for treatment of respiratory syncytial virus in lung transplantation recipients","volume":"53","author":"Martin-Cerezuela","year":"2021","journal-title":"Transplant Proc"},{"key":"2026112004315130700_ofag623-B30","author":"ASHP"},{"key":"2026112004315130700_ofag623-B31","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/TP.0b013e3181d05a71","article-title":"A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients","volume":"89","author":"Kumar","year":"2010","journal-title":"Transplantation"},{"key":"2026112004315130700_ofag623-B32","doi-asserted-by":"crossref","first-page":"S1732","DOI":"10.21037\/jtd.2019.03.83","article-title":"Detection, classification, and management of rejection after lung transplantation","volume":"11","author":"Parulekar","year":"2019","journal-title":"J Thorac Dis"},{"key":"2026112004315130700_ofag623-B33","doi-asserted-by":"crossref","first-page":"i105","DOI":"10.1093\/cid\/ciag114","article-title":"IDSA 2025 guidelines on the use of vaccines for the prevention of seasonal COVID-19, influenza, and RSV infections in immunocompromised patients","volume":"82","author":"Nellore","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026112004315130700_ofag623-B34","doi-asserted-by":"crossref","first-page":"e1112","DOI":"10.1093\/cid\/ciag108","article-title":"Respiratory syncytial virus vaccination in solid organ transplant recipients: interim findings from a phase 3 trial of mRNA-1345","volume":"82","author":"Mayer","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026112004315130700_ofag623-B35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/vaccines13040398","article-title":"Neutralizing antibody response to the AreXvy respiratory syncytial virus vaccine in lung transplant recipients: assessment against reference and seasonal strains","volume":"13","author":"Levy","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"2026112004315130700_ofag623-B36","doi-asserted-by":"crossref","first-page":"e70128","DOI":"10.1111\/tid.70128","article-title":"Epidemiology and clinical impact of confirmed respiratory viral infections in solid organ transplant recipients","volume":"28","author":"Prins","year":"2026","journal-title":"Transpl Infect Dis"},{"key":"2026112004315130700_ofag623-B37","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf695.062","article-title":"184. incidence and clinical outcomes of RSV and influenza in solid organ transplant recipients","volume":"13","author":"Le","year":"2026","journal-title":"Open Forum Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag623\/71629133\/ofag623.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/11\/ofag623\/71629133\/ofag623.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/11\/ofag623\/71629133\/ofag623.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T09:32:00Z","timestamp":1795167120000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag623\/8869214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag623","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,10,8]]},"article-number":"ofag623"}}